Buscar
Clearmind Medicine Inc
CMNDAñadir a la lista de seguimiento
2.360USD
+0.060+2.61%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
240.51KCap. mercado
PérdidaP/E TTM
Más Datos de Clearmind Medicine Inc Compañía
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Información de Clearmind Medicine Inc
Símbolo de cotizaciónCMND
Nombre de la empresaClearmind Medicine Inc
Fecha de salida a bolsaAug 10, 2021
Director ejecutivoZuloff-Shani (Adi)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 10
Dirección101-1220 West 6Th Avenue
CiudadVANCOUVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísCanada
Código postalV6H 1A5
Teléfono16042601566
Sitio Webhttps://www.clearmindmedicine.com/
Símbolo de cotizaciónCMND
Fecha de salida a bolsaAug 10, 2021
Director ejecutivoZuloff-Shani (Adi)
Ejecutivos de Clearmind Medicine Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Clearmind Medicine Inc?
Los cinco principales accionistas de Clearmind Medicine Inc son: Mr. Amitay Weiss
¿Cuántas instituciones poseen acciones de Clearmind Medicine Inc (CMND)?
A fecha de 2026Q1, 18 instituciones poseen acciones de Clearmind Medicine Inc, con un valor de mercado combinado de aproximadamente 7.38K, lo que representa el 0.49% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -15258.00.